Pacific Biosciences of California, Inc. <PACB.O>: UBS cuts target price to $1.35 from $1.5
PACB•Related News
Silo Pharma attends IPAC-RS Nasal Innovation Forum, spotlights SPC-15 nose-to-brain PTSD delivery technology
SILO•
WD-sponsored IDC study says AI adoption drives compounding enterprise storage demand
WDC•
Midland States Bancorp COO Kyle Owen Mooney sells 2,400 common shares worth $79,992
MSBI•
Amex halt WZRD add info lst 12.762800
WZRD•
Omada cites independent model projecting $11,142 gross medical cost savings per member over five years for GLP-1 program
OMDA•